Biotech · Public company · Watertown, MA, US
Enanta Pharmaceuticals Inc
Ticker ENTA · SEC CIK 0001177648
Track this companyFree. Adds Enanta Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs43From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline43
- zelicapavirPhase 3 · RSVClinicalTrials.gov · fetched Nov 12, 2026
- EDP-235Phase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- EDP-305 1 mgPhase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP-305 1.5 mgPhase 2 · Non-Alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP-305 2 mgPhase 2 · Non-Alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP-305 2.5 mgPhase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP-305 Dose 1Phase 2 · Non-Alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP-305 Dose 2Phase 2 · Non-Alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP-938Phase 2 · Respiratory Syncytial VirusClinicalTrials.gov · fetched Nov 12, 2026
- EDP-938Phase 2 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- EDP-938Phase 2 · Respiratory Syncytial Virus (RSV)ClinicalTrials.gov · fetched Nov 12, 2026
- EDP-938Phase 2 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- CaffeinePhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CaffeinePhase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- CarbamazepinPhase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- carbamazepinePhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CarbamazepinePhase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- CyclosporinePhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- DabigatranPhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- EDP-235Phase 1 · SARS CoV 2 InfectionClinicalTrials.gov · fetched Nov 12, 2026
- EDP-305Phase 1 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP-323Phase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- EDP-514Phase 1 · Chronic HBV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- EDP-514Phase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- EDP-978Phase 1 · Chronic Inducible UrticariaClinicalTrials.gov · fetched Nov 12, 2026
- FluconazolePhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- moxifloxacinPhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Oral ContraceptivePhase 1 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- PrednisonePhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- QuinidinePhase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- QuinidinePhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- QuinidinePhase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- RosuvastatinPhase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- RosuvastatinPhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TacrolimusPhase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- zelicapavir (supratherapeutic dose)Phase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- zelicapavir (therapeutic dose)Phase 1 · RSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe DiseasePHASE2_PHASE3 · RECRUITING · started Oct 19, 2026ClinicalTrials.gov NCT07908381 · fetched Nov 12, 2026
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy AdultsPHASE1 · RECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT07540910 · fetched Nov 12, 2026
- A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy ParticipantsPHASE1 · COMPLETED · started Mar 13, 2025ClinicalTrials.gov NCT06917508 · fetched Nov 12, 2026
- A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.PHASE1 · COMPLETED · started Jan 27, 2025ClinicalTrials.gov NCT06847464 · fetched Nov 12, 2026
- A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy AdultsPHASE1 · COMPLETED · started Jul 15, 2024ClinicalTrials.gov NCT06601192 · fetched Nov 12, 2026
- A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.PHASE2 · COMPLETED · started Nov 29, 2022ClinicalTrials.gov NCT05568706 · fetched Nov 12, 2026
- A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19PHASE2 · COMPLETED · started Nov 10, 2022ClinicalTrials.gov NCT05616728 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy SubjectsPHASE1 · COMPLETED · started Oct 6, 2022ClinicalTrials.gov NCT05594615 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.PHASE1 · COMPLETED · started Oct 6, 2022ClinicalTrials.gov NCT05594602 · fetched Nov 12, 2026
- A Study of EDP-323 in Healthy SubjectsPHASE1 · COMPLETED · started Sep 29, 2022ClinicalTrials.gov NCT05587478 · fetched Nov 12, 2026
- A Study to Evaluate EDP 938 Regimens in Children With RSVPHASE2 · COMPLETED · started Apr 26, 2022ClinicalTrials.gov NCT04816721 · fetched Nov 12, 2026
- A Study of EDP-235 in Healthy SubjectsPHASE1 · COMPLETED · started Jan 28, 2022ClinicalTrials.gov NCT05246878 · fetched Nov 12, 2026
- Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory TractPHASE2 · TERMINATED · started Jul 7, 2021ClinicalTrials.gov NCT04633187 · fetched Nov 12, 2026
- Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male SubjectsPHASE1 · COMPLETED · started May 28, 2021ClinicalTrials.gov NCT04927793 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy SubjectsPHASE1 · COMPLETED · started Mar 12, 2021ClinicalTrials.gov NCT04871724 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy SubjectsPHASE1 · COMPLETED · started Nov 5, 2020ClinicalTrials.gov NCT04783753 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy SubjectsPHASE1 · COMPLETED · started Jul 8, 2020ClinicalTrials.gov NCT04498741 · fetched Nov 12, 2026
- A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASHPHASE2 · TERMINATED · started Jan 27, 2020ClinicalTrials.gov NCT04378010 · fetched Nov 12, 2026
- A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult SubjectsPHASE2 · COMPLETED · started Jan 22, 2020ClinicalTrials.gov NCT04196101 · fetched Nov 12, 2026
- A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)PHASE1 · COMPLETED · started Jun 26, 2019ClinicalTrials.gov NCT04008004 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy SubjectsPHASE1 · COMPLETED · started Nov 29, 2018ClinicalTrials.gov NCT03755778 · fetched Nov 12, 2026
- A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female SubjectsPHASE1 · COMPLETED · started Nov 27, 2018ClinicalTrials.gov NCT03783897 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult SubjectsPHASE1 · COMPLETED · started Nov 2, 2018ClinicalTrials.gov NCT03750383 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic SteatohepatitisPHASE2 · COMPLETED · started Apr 25, 2018ClinicalTrials.gov NCT03421431 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary CholangitisPHASE2 · COMPLETED · started Dec 27, 2017ClinicalTrials.gov NCT03394924 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 28, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 23, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Feb 11, 2026 · fetched Nov 12, 2026